Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)

Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)

  • March 2019 •
  • 66 pages •
  • Report ID: 5754024 •
  • Format: PDF
Scope of the Report
The report entitled “Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)”, provides an analysis of the global small molecule CMO market with market sizing and growth. The analysis includes market size in terms of value, market share by segments, and by region. A brief segment analysis of small molecule CMO market has also been provided. Moreover, an overview of pharmaceutical industry and contract manufacturing industry has included in the report.

The report also assesses the key opportunities available in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the small molecule CMO market has forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The small molecule CMO market is highly fragmented, as the top ten players accounted for less than half market share globally. Lonza Group, Wuxi AppTec Co., Ltd., Catalent, Inc., and Patheon Inc. are key companies in the global market whose company profiling has been done in the report. This segment of the report provides business overview, financial overview, and business strategies adopted by the respective companies.

Company Coverage
Lonza Group
Wuxi AppTec Co., Ltd
Catalent, Inc.
Patheon Inc.

Region Coverage

The U.S

Executive Summary
The pharmaceutical industry primarily encompassed a large number of private as well as public organizations that discover, develop, produce, and market drugs for medicinal use. It is considered as one of the vital component of health care system worldwide. On the basis of molecule types, pharmaceutical drugs can be categorized into small molecule or conventional drugs, and large molecules or biologic drugs.

Small molecules are primarily made up of naturally occurring compounds which have been isolated or re-synthesized in the laboratory. These are interchangeably called as drugs. Majority of drugs are come under the category of small molecules. Small molecules are well defined, and independent of manufacturing process.

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm. Sometimes CMOs are also referred as contract development and manufacturing organization (CDMO).

The global small molecule CMO market has shown upward trends over the past few years and projections are made that the market would follow the same trends in the next five years (2019-2023) as well. The market is expected to grow at a significant growth rate over the forecasted period. Growing pharmaceutical industry and rising demand for oncology drugs are the major factors that are driving the growth of the market. Other growth drivers such as growing demand for process development CMO services, robust pipeline of small molecule drugs & increasing rate of FDA approvals, mergers & acquisitions, growing demand for CDMOs offering highly potent API etc. are expected to boost the growth of the market in the near future.

We are very sorry, but an error occurred.
Please contact if the problem remains.